Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

353
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
353
Neural Regulation01:37

Neural Regulation

39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

350
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
350
Dementia01:30

Dementia

76
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
76
Prosopagnosia01:24

Prosopagnosia

113
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
113

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuropsychiatric symptoms and social cognition in frontotemporal dementia and Alzheimer's disease.

Dementia & neuropsychologia·2026
Same author

A Biological Framework for Parkinson's Disease: Advances in α-Synuclein-Centered Biomarkers and Staging.

Journal of neurochemistry·2026
Same author

The Myth of Tithonus: Ageing and Dementia in Ancient Greek Thought.

Journal of geriatric psychiatry and neurology·2026
Same author

Biological pathways related to mirna-125a-5p in behavioral variant of frontotemporal dementia.

Molecular biology reports·2026
Same author

Levodopa-Induced dyskinesia in Latin America: Prevalence and associated clinical factors in the LARGE-PD cohort.

Journal of Parkinson's disease·2026
Same author

Spatial memory retrieval under cueing in behavioral frontotemporal dementia and Alzheimer's disease.

Dementia & neuropsychologia·2026

Related Experiment Video

Updated: May 16, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.1K

Does Midbrain Atrophy Distinguish Progressive Supranuclear Palsy from Frontotemporal Dementia?

Mauro César Quintão E Silva Cunningham1,2, Sarah Teixeira Camargos1,3,4, Vinícius Ribeiro Jeunon2

  • 1Ambulatório de Distúrbios de Movimento, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.

Movement Disorders Clinical Practice
|April 2, 2025
PubMed
Summary

Midbrain atrophy measures offer moderate accuracy in differentiating progressive supranuclear palsy (PSP) from behavioral variant frontotemporal dementia (bvFTD). Specific metrics like midbrain area and brainstem volume showed the highest diagnostic potential in this study.

Keywords:
frontotemporal dementiamidbrain atrophyneuroimagingparkinsonismprogressive supranuclear palsy

More Related Videos

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

13.9K
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

28.2K

Related Experiment Videos

Last Updated: May 16, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.1K
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

13.9K
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

28.2K

Area of Science:

  • Neuroimaging
  • Neurology
  • Dementia Research

Background:

  • Distinguishing between behavioral variant frontotemporal dementia (bvFTD) and progressive supranuclear palsy (PSP) is diagnostically challenging.
  • The role of midbrain atrophy in differentiating these conditions remains unclear.

Purpose of the Study:

  • To evaluate the diagnostic value of midbrain atrophy measures in differentiating PSP from bvFTD.
  • To compare quantitative and qualitative atrophy metrics between patient groups and healthy controls.

Main Methods:

  • Included four groups: healthy controls, PSP, bvFTD, and Parkinson's disease (PD).
  • Assessed midbrain atrophy using the Hummingbird sign rating scale (HBS-RS), global midbrain atrophy (GMA), midbrain area, midbrain/pons ratio, Magnetic Resonance Parkinsonism Index (MRPI) 2.0, and brainstem volume.

Main Results:

  • PSP and bvFTD groups exhibited reduced midbrain area, HBS-RS, and GMA compared to controls.
  • Several measures, including midbrain area (83%) and brainstem volume (82%), demonstrated modest accuracy in distinguishing PSP from bvFTD.

Conclusions:

  • Both quantitative and qualitative midbrain atrophy assessments provide moderate accuracy for differentiating PSP from bvFTD.
  • These findings contribute to understanding neuroimaging markers for differential diagnosis in neurodegenerative diseases.